Cointime

Librede

company

About

High Quality Pharmaceuticals from Yeast.

  • 1 - 10

Highlights

Total Funding Amount
$1.63M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.49M
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

Librede Inc. is a company that has a mission to improve the quality of life through innovated sustainable technologies. Librede focuses on the creation of platform technologies that enable the creation of new therapeutics; they use biology to build devices and manufacture molecules. They have developed the world’s first biosynthetic production platform that is targeting the endocannabinoid system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.63M
Librede has raised a total of $1.63M in funding over 2 rounds. Their latest funding was raised on Feb 13, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 13, 2018 Grant $1.49M 1 National Center for Complementary and Integrative Health (NCCIH) — Detail
Jun 5, 2012 Grant $149.99K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Librede is funded by 2 investors. National Center for Complementary and Integrative Health (NCCIH) and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Center for Complementary and Integrative Health (NCCIH) Yes Grant
National Science Foundation Yes Grant
Cointime
Содержание
компания